You are here: Industry Insights > Sputnik V

News List

RDIF announces Sputnik V efficacy data from San Marino ExpressPharma
November 26, 2021
The Russian Direct Investment Fund (RDIF) yesterday announced new positive real-world data of the Ministry of Health of the Republic of San Marino on efficacy of the Russian Sputnik V vaccine...
Serbia authorizes third shot of COVID-19 vaccine, minister says firstwordpharma
August 16, 2021
Serbia's health authorities authorized a third dose of COVID-19 vaccines for people with compromised immune systems, health workers and anyone vaccinated at least six months ago, as reported in the National Post.
Combination of the first component of Sputnik V vaccine (Sputnik Light vaccine) with vaccines by AstraZeneca, Sinopharm and Moderna demonstrates high safety profile during the study in Argentina’s Bue firstwordpharma
August 05, 2021
RDIF announces the initial safety results of the randomized, single-blind study for the evaluation of the immune response and safety of heterogeneous regimens combining the first component of the Russian Sputnik V vaccine against coronavirus.
AstraZeneca and Sputnik V combination show no adverse events: RFID expresspharma
August 02, 2021
The world’s first study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine (Sputnik Light) in Azerbaijan shows no serious adverse events or COVID infection cases following the vaccination.
Sputnik V vaccine production in India to go fully on stream in September: RDIF firstwordpharma
August 02, 2021
The Russian Direct Investment Fund (RDIF) said that production of the Sputnik V COVID-19 vaccine in India is expected to start in September, The Economic Times reported Sunday.
First batches of the Sputnik V vaccine produced in Uzbekistan by Jurabek Laboratories firstwordpharma
August 02, 2021
RDIF, Russia's sovereign wealth fund, and one of the leading pharmaceutical companies of Uzbekistan, Jurabek Laboratories, today announced the first batches of the Russian Sputnik vaccine against coronavirus have been produced at company's facilities.
Russia’s global vaccine ambitions stumble during supply shortage firstwordpharma
August 02, 2021
Deliveries of Russia's Sputnik V COVID-19 vaccine have been hampered, forcing countries to seek alternatives, Bloomberg reported.
Swedish company ZandCell offers Russia 750 million dose vaccine capacity for Sputnik V and Aurora prnewswire
July 30, 2021
ZandCell, a biotech company with a proven track record in immunotherapies and COVID-19 diagnostics is announcing that it wants to manufacture the Russian vaccines for worldwide distribution.
One shot of the Sputnik V vaccine triggers strong antibody responses worldpharmanews
July 14, 2021
A single dose of the Sputnik V vaccine may elicit significant antibody responses against SARS-CoV-2, finds a study published July 13 in the journal Cell Reports Medicine.
Shortage of Sputnik V’s second dose to delay India’s full roll out, says Dr Reddy’s expresspharma
July 14, 2021
Dr Reddy's had received about three million first doses by 1st June and about 360,000 doses of the second by early this month, the company and the Indian government have said.

Previous page 1 2 3 4 5 6 7 8 Next page